Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g Meeting Abstract
| Authors: | Krop, I. E.; Suter, T. M.; Dirix, L.; Romieu, G.; Zamagni, C.; Citron, M. L.; Campone, M.; Dang, C. T.; Xu, N.; Smitt, M.; Gianni, L. |
| Abstract Title: | Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496901048 |
| DOI: | 10.1158/0008-5472.sabcs13-p2-15-03 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-15-03 -- Source: Wos |
